Salesforce Stock’s Dreamforce Test Starts Tomorrow With cRPO Growth at 14%
Salesforce shares rose 2.61% to $254.19. The company's Dreamforce event and investor session will test its AI growth case. Current remaining performance obligation (cRPO) grew 14% to $33.5 billion. Revenue grew 11% to $11.3 billion, including $456 million from Informatica. The company aims for $46.1B-$46.4B in full-year revenue and 14% cRPO growth in Q3.
How this was made

The 30-second read
Why it matters
The disclosed cRPO and revenue guidance provide a concrete metric for evaluating the sustainability of AI bookings.
Market read
Fresh guidance and cRPO data create a short‑term trading opportunity ahead of the analyst day.
What to watch
The $25B share‑repurchase program settlement delay and potential macro slowdown could temper upside.
Background
Salesforce is using Dreamforce to showcase AI product adoption and to address investor concerns about acquisition‑driven growth.
Ticker impact
Salesforce reported fiscal Q2 cRPO of $33.5B, up 14% YoY, and gave FY revenue guidance of $46.1B‑$46.4B ahead of Dreamforce events.
Potential modest upside if investor session confirms organic growth beyond Informatica acquisition.
Guidance and cRPO numbers are fresh disclosures; traders can position ahead of the analyst day.
Market effects
AI‑focused enterprise software sector may see broader lift as cRPO growth validates demand.
U.S. tech equities could benefit from positive sentiment around AI contracts.
Global investors tracking AI spend may adjust exposure to cloud and SaaS names.
Counterpoint
cRPO growth may be inflated by one‑time Informatica acquisition revenue; organic AI demand could lag.
Key entities
- ExecutiveMarc Benioff
Chair and CEO presenting at the investor session.
- Acquired CompanyInformatica
Contributed $456M to quarterly revenue and ~4 percentage points of FY growth.





